This is interesting.And you wonder why its NTA is not reported in its Appendix 4E but hidden on note 27 of the annual report. I have always thought it is a listing rule requirement to be disclosed at the front.
And the NTA was on the back of a reversal of impairment losses as disclosed on note 8 of the annual report (pg 49) due to previous poor performance in 2017 has improved in 2018. And assets being discounted at a high rate of 15.8% which appears conservative (stand corrected). So has business improved or worsen?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.65 |
Change
0.000(0.00%) |
Mkt cap ! $248.4M | |||
| Open | High | Low | Value | Volume |
| $6.64 | $6.67 | $6.64 | $403.8K | 60.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2816 | $6.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.67 | 7474 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| TRS (ASX) Chart |